Location: St. Helier, Jersey
CIK: 0001839209 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $3.771B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 2,211,018 | $205M | 5.4% | $103.02 | 0.0% | COM | 76155X100 |
| ROIV | ROIVANT SCIENCES LTD | 6,797,300 | $180M | 4.8% | $24.17 | 0.0% | SHS | G76279101 |
| DNTH | DIANTHUS THERAPEUTICS INC | 17,357 | $1.457M | 0.0% | $47.58 | 0.0% | COM | 252828108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 3,468,657 (+9.1%) | $352M (-19.9%) | 9.3% | $84.85 | — | SPONSORED ADS | 00370M103 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CIDARA THERAPEUTICS INC | 997,196 | $220M | 5.8% | $59.96 | — | — | 171757206 |
| WVE | WAVE LIFE SCIENCES LTD | 7,298,421 | $125M | 3.3% | $10.16 | +35.3% | — | Y95308105 |
| CAPR | CAPRICOR THERAPEUTICS INC | 800,000 | $23.17M | 0.6% | $13.06 | +90.5% | — | 14070B309 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 16,805,184 (-19.7%) | $2.577B (-29.3%) | 68.3% | $73.54 | +116.2% | COM PAR $.01 | 457669307 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BLTE | BELITE BIO INC | 3,057,412 | $456M | 12.1% | $160.82 | — | SPONSORED ADS | 07782B104 |